Spectrum Pharmaceutecals Inc (SPPI)

[Tartiaboy]

I think genotyping is fast becoming a mandatory requirement just like cancer identification and staging before treatment.

It has already started in the well funded research institutions, but will quickly move into most regional cancer centers. There is just too much new cancer research and drug development that depends on genotyping. I expect that in just a few more years it will be routine.

I imagine SPPI is doing whatever they can to support genotyping access for the Pozi trial cohorts.